NRG GY020

Primary Category:

Cancer Care Delivery, Radiation Oncology

Disease Category:

Endometrial, Gynecologic

Status:

New, Open

A Phase III Randomized Trial of Radiation +/- MK-3475 (Pembrolizumab) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer

Eligible for screening study DCP 001

NCT#04214067